| Revision as of 22:15, 3 February 2002 edit130.94.122.xxx (talk)m ®← Previous edit | Revision as of 15:51, 25 February 2002 edit undoRoseParks (talk | contribs)303 editsmNo edit summaryNext edit → | ||
| Line 1: | Line 1: | ||
| '''Selective serotonin reuptake inhibitors''' (SSRI) are a class of ]. They act within the brain to increase the amount of the ], ] (5-hydroxy-tryptamine or 5-HT). One notable characteristic of SSRI's is | '''Selective serotonin reuptake inhibitors''' (SSRI)s are a class of ]. They act within the brain to increase the amount of the ], ] (5-hydroxy-tryptamine or 5-HT). One notable characteristic of SSRI's is | ||
| that unlike other classes of antidepressants, SSRI's were ]. Instead of being discovered by accident, SSRI's were | that, unlike other classes of antidepressants, SSRI's were ]. Instead of being discovered by accident, SSRI's were | ||
| specifically designed while considering the biological causes of depression. | specifically designed while considering the biological causes of depression. | ||
| Like other antidepressants, SSRI's are not addictive. Their effectiveness | Like other antidepressants, SSRI's are not addictive. Their effectiveness | ||
| does not appear to be higher than ]s which were the most commonly used class of antidepressants before the SSRI's. However, SSRI's have the important advantage that the toxic dose is high, and therefore they much more difficult to use as a means to commit suicide. | does not appear to be higher than ]s which were the most commonly used class of antidepressants before the SSRI's. However, SSRI's have the important advantage that the toxic dose is high, and, therefore, they much more difficult to use as a means to commit suicide. | ||
| Many drugs in this class are familiar through advertising, including | Many drugs in this class are familiar through advertising, including | ||
| Line 11: | Line 11: | ||
| * ] (trade name: <strong>Paxil®</strong>) | * ] (trade name: <strong>Paxil®</strong>) | ||
| In the ], information |
In the ], information is passed between two ]s (nerve cells) via a ], a small gap between the cells. The neuron that sends the information releases neurotransmitters (with serotonin among them) into that gap. The neurotransmitters are then recognized by ]s on the surface of the recipient cell, which upon this stimulation in turn relays the signal. About 10% of the neurotransmitters are lost in this process, the other 90% are released from the receptors and taken up again by the sending cell (thus ''reuptake''). | ||
| ] can be caused by a lack of stimulation of the recipient neuron at a synapse. To stimulate the recipient cell, SSRIs inhibit the reuptake of serotonin. As a result, the serotonin stays in the synaptic gap longer than it normally |
] can be caused by a lack of stimulation of the recipient neuron at a synapse. To stimulate the recipient cell, SSRIs inhibit the reuptake of serotonin. As a result, the serotonin stays in the synaptic gap longer than it normally would, and has the chance to be recognized again (and again) by the receptors of the recipiant cell, which can finally be stimulated that way. | ||
| Why not give serotonin directly? First, pure serotonin would turn on ''every'' synapse it reaches, whereas SSRIs only ''enhance a signal'' that is already present, but too weak to come through. Second, the first letter of SSRI standing for selective indicates that not all synapses are affected, but only ''selectively'' those that are responsible for the the mood and, thus, the depression. | Why not give serotonin directly? First, pure serotonin would turn on ''every'' synapse it reaches, whereas SSRIs only ''enhance a signal'' that is already present, but too weak to come through. Second, the first letter of SSRI standing for "selective" indicates that not all synapses are affected, but only ''selectively'' those that are responsible for the the mood and, thus, the depression. | ||
| External links: | External links: | ||
Revision as of 15:51, 25 February 2002
Selective serotonin reuptake inhibitors (SSRI)s are a class of antidepressants. They act within the brain to increase the amount of the neurotransmitter, serotonin (5-hydroxy-tryptamine or 5-HT). One notable characteristic of SSRI's is that, unlike other classes of antidepressants, SSRI's were rationally designed drugs. Instead of being discovered by accident, SSRI's were specifically designed while considering the biological causes of depression.
Like other antidepressants, SSRI's are not addictive. Their effectiveness does not appear to be higher than tricyclic antidepressants which were the most commonly used class of antidepressants before the SSRI's. However, SSRI's have the important advantage that the toxic dose is high, and, therefore, they much more difficult to use as a means to commit suicide.
Many drugs in this class are familiar through advertising, including
- fluoxetine (trade name: Prozac®)
- sertraline (trade name: Zoloft®)
- paroxetine (trade name: Paxil®)
In the brain, information is passed between two neurons (nerve cells) via a synapse, a small gap between the cells. The neuron that sends the information releases neurotransmitters (with serotonin among them) into that gap. The neurotransmitters are then recognized by receptors on the surface of the recipient cell, which upon this stimulation in turn relays the signal. About 10% of the neurotransmitters are lost in this process, the other 90% are released from the receptors and taken up again by the sending cell (thus reuptake).
Depression can be caused by a lack of stimulation of the recipient neuron at a synapse. To stimulate the recipient cell, SSRIs inhibit the reuptake of serotonin. As a result, the serotonin stays in the synaptic gap longer than it normally would, and has the chance to be recognized again (and again) by the receptors of the recipiant cell, which can finally be stimulated that way.
Why not give serotonin directly? First, pure serotonin would turn on every synapse it reaches, whereas SSRIs only enhance a signal that is already present, but too weak to come through. Second, the first letter of SSRI standing for "selective" indicates that not all synapses are affected, but only selectively those that are responsible for the the mood and, thus, the depression.
External links: